Status:
WITHDRAWN
rTMS for the Treatment of Primary Progressive Aphasia: A Randomized Controlled Trial
Lead Sponsor:
Peking Union Medical College Hospital
Conditions:
Aphasia, Primary Progressive
Repetitive Transcranical Magnetic Stimulation
Eligibility:
All Genders
35-75 years
Phase:
NA
Brief Summary
The primary progressive aphasia (PPA) is a neurodegenerative condition characterized by a gradual, irreversible decline of language function (Mesulam, 2001). There are no known treatments for PPA so f...
Eligibility Criteria
Inclusion
- All participants had also been evaluated previously by a behavioral neurologist at the Peking Union Medical College Hospital and had been clinically diagnosed with a variant of PPA.
Exclusion
- Scored below 15 on the mini-mental state exam (MMSE) due to concerns that global cognitive impairment might preclude their ability to follow the directions and interfere with task performance.
- Had a history of seizures or unexplained loss of consciousness, pregnancy, surgical breach of the skull, or any other medical or surgical contraindication to receiving noninvasive brain stimulation.
- Is unable to complete the treatment and evaluations
Key Trial Info
Start Date :
March 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2021
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03448133
Start Date
March 1 2018
End Date
December 31 2021
Last Update
June 5 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.